Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury

The Acquisition of Blood and Skin Samples From Normal Volunteers to Support Research Activities on Dermatologic Diseases

NCT00001505 ·Status: COMPLETED

Swiss Itch Registry

NCT06120907 ·Status: RECRUITING

Cutaneous Microcirculation and Nervous Sensitivity in Psoriasis

NCT02652065 ·Status: COMPLETED ·Phase: NA

A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis

NCT02597933 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa

NCT01538862 ·Status: COMPLETED ·Phase: PHASE2

Evaluation and Treatment of Patients With Dermatologic Diseases

NCT00001506 ·Status: COMPLETED

Research in Skin Inflammation

NCT00026741 ·Status: COMPLETED

Establishment of a Patient Library in Patients With Pruritus Sine Materia

NCT05678309 ·Status: NOT_YET_RECRUITING

Safety, Tolerability, Efficacy, and Pharmacokinetics of JBT-101 in Systemic Sclerosis

NCT02465437 ·Status: TERMINATED ·Phase: PHASE2

Efficacy of Botulinum Toxin In Scleroderma-Associated Raynaud's Syndrome

NCT02165111 ·Status: COMPLETED ·Phase: PHASE3

Studies of Dermatologic Diseases Biospecimen Acquisition Protocol

NCT02471352 ·Status: RECRUITING

Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic Sclerosis

NCT00043706 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Platform Clinical Study for Conquering Scleroderma

NCT06195072 ·Status: RECRUITING ·Phase: PHASE2

A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy

NCT00936546 ·Status: COMPLETED ·Phase: PHASE2

Physiopathological Study and Pharmacological Modulation of Cutaneous Atrophy's Markers Induced by Glucocorticoids

NCT00709579 ·Status: UNKNOWN ·Phase: PHASE3

Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis

NCT03585946 ·Status: WITHDRAWN

Pathophysiological Study of the Sensitive Scalp

NCT07156422 ·Status: RECRUITING ·Phase: NA

Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis Bullosa

NCT03578029 ·Status: TERMINATED ·Phase: PHASE2

Prevalence and Subjective Impairment of Quality of Life (QoL) Due to Dermatologic Diseases in Internal Medicine Patients

NCT01044043 ·Status: COMPLETED

Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial

NCT02349009 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study to Evaluate the Use of Palifermin to Treat Toxic Epidermal Necrolysis

NCT02037347 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Early Screening Markers of Herpes Zoster Neuralgia

NCT07038707 ·Status: NOT_YET_RECRUITING

Clinical Characteristics of Pruritus and Evaluation of Quality of Life in Patients With Bullous Pemphigoid

NCT03272958 ·Status: COMPLETED

A Non-interventional Study to Describe the Dupilumab Long-term Treatment, Safety and Patient Reported Outcomes in Chronic Nodular Prurigo (Prurigo Nodularis) in Clinical Routine

NCT06087627 ·Status: RECRUITING

A Study to Explore Safety, Pharmacokinetics, and Early Clinical Signal of Efficacy of DS-2325a in Patients With Netherton Syndrome

NCT05979831 ·Status: TERMINATED ·Phase: PHASE1/PHASE2